Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Cash Flows

v3.19.3.a.u2
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities      
Net income $ 1,175 $ 1,274 $ 490
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization expense 527 424 339
Amortization of debt issuance costs, deferred commitment fees, premium and discount 34 30 36
Loss on modification or extinguishment of debt 13 12 67
Total losses (gains) on derivatives, net (72) 87 20
Net cash provided by (used for) settlement of derivative instruments 5 32 (16)
Impairment expense and loss on disposal of assets 7 8 2
Other 11 5 6
Other—affiliate (2) 0 0
Changes in operating assets and liabilities:      
Accounts and other receivables 16 (122) (101)
Accounts receivable—affiliate 9 47 (62)
Advances to affiliate (41) (84) (12)
Inventory (16) (5) 13
Accounts payable and accrued liabilities (126) 183 210
Due to affiliates 6 (6) (42)
Deferred revenue 39 3 34
Other, net (36) (12) (5)
Other, net—affiliate (2) (2) (2)
Net cash provided by operating activities 1,547 1,874 977
Cash flows from investing activities      
Property, plant and equipment, net (1,331) (804) (1,290)
Other (1) 0 0
Net cash used in investing activities (1,332) (804) (1,290)
Cash flows from financing activities      
Proceeds from issuances of debt 2,230 1,100 3,814
Repayments of debt (730) (1,090) (2,173)
Debt issuance and deferred financing costs (35) (8) (50)
Debt extinguishment costs   (7)  
Distributions to owners (1,260) (1,113) (294)
Other 1 (7) 0
Net cash provided by (used in) financing activities 206 (1,118) 1,297
Net increase (decrease) in cash, cash equivalents and restricted cash 421 (48) 984
Cash, cash equivalents and restricted cash—beginning of period 1,541 1,589 605
Cash, cash equivalents and restricted cash—end of period $ 1,962 $ 1,541 $ 1,589